Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 

4-Traders Homepage  >  Equities  >  Nasdaq  >  Regeneron Pharmaceuticals Inc    REGN

Delayed Quote. Delayed  - 09/26 07:06:25 pm
402.65 USD   -1.89%
07:49aDJSANOFI : FDA Accepts Sanofi's, Regeneron's Dermatitis Treatment for ..
09/20 REGENERON PHARM : Teva buys rights to Regeneron chronic pain drug fo..
09/20 Bayer raises sales targets for top-selling drugs after Monsanto d..
 SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/20/2016 09/21/2016 09/22/2016 09/23/2016 09/26/2016 Date
406.24(c) 406.52(c) 408.01(c) 410.39(c) 402.65 Last
626 928 751 396 621 493 689 342 273 378 Volume
+0.85% +0.07% +0.37% +0.58% -1.89% Change
More quotes
Financials ($)
Sales 2016 5 073 M
EBIT 2016 1 798 M
Net income 2016 731 M
Finance 2016 961 M
Yield 2016 -
Sales 2017 6 021 M
EBIT 2017 2 238 M
Net income 2017 1 091 M
Finance 2017 1 535 M
Yield 2017 -
P/E ratio 2016 67,41
P/E ratio 2017 46,27
EV / Sales2016 8,33x
EV / Sales2017 6,92x
Capitalization 43 212 M
More Financials
Company
Regeneron Pharmaceuticals, Inc. operates as a biopharmaceutical company.It discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions.The company involves in marketing medicines for eye diseases, colorectal cancer and a rare inflammatory... 
More about the company
Surperformance© ratings of Regeneron Pharmaceuticals
Trading Rating : Investor Rating :
More Ratings
Latest news on REGENERON PHARMACEUTICALS
07:49aDJSANOFI : FDA Accepts Sanofi's, Regeneron's Dermatitis Treatment for Priority Rev..
09/22 REGENERON PHARMACEUTICALS : Assigned Patent
09/20 REGENERON PHARMACEUTICALS : Teva buys rights to Regeneron chronic pain drug for ..
09/20 REGENERON PHARMACEUTICALS INC : Entry into a Material Definitive Agreement (form..
09/20 Bayer raises sales targets for top-selling drugs after Monsanto deal
09/14 REGENERON PHARMACEUTICALS INC : Change in Directors or Principal Officers (form ..
09/09 REGENERON PHARMACEUTICALS : Findings from Regeneron Pharmaceuticals Reveals New ..
09/09 REGENERON PHARMACEUTICALS : Patent Application Titled "Syringe Systems, Piston S..
09/01 REGENERON PHARMACEUTICALS : Patent Application Titled "Remotely Activated Drug D..
09/01 REGENERON PHARMACEUTICALS : Announces Agreement with BARDA for the Manufacturing..
More news
Sector news : Bio Therapeutic Drugs
02:38p Pfizer abandons plan to split into two
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- 2nd Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira -- Update
09/23DJAMGEN : FDA Approves Amgen's Biosimilar Version of Humira
09/21DJGILEAD SCIENCES : Halts Test of Bowel Disease Treatment
More sector news : Bio Therapeutic Drugs
News from SeekingAlpha
06:58a FDA accepts dupilumab BLA for review; action date March 29, 2017
01:50a Amgen's New Products Have Ample Insurance Coverage In The U.S.
09/25 TEVA : Buy For Today's Value And Tomorrow's Growth
09/23 Fovista Results Could See Novartis Dig Deep, And Gilead's NASH Data
09/22 In Teva, Regeneron Finds Its Sanofi For Pain
Advertisement
Chart REGENERON PHARMACEUTICALS
Duration : Period :
Regeneron Pharmaceuticals  Technical Analysis Chart | REGN | US75886F1075 | 4-Traders
Full-screen chart
Technical analysis trends REGENERON PHARMAC...
Short TermMid-TermLong Term
TrendsNeutralBullishBearish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 26
Average target price 468 $
Spread / Average Target 14%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Leonard S. Schleifer President, CEO & Class I Director
P. Roy Vagelos Chairman
Robert E. Landry Chief Financial Officer & Senior VP-Finance
George Damis Yancopoulos Class I Director & Chief Scientific Officer
Charles A. Baker Independent Class III Director
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
REGENERON PHARMACEUTIC..-24.40%43 212
AMGEN, INC.7.68%130 813
GILEAD SCIENCES, INC.-19.59%107 381
CELGENE CORPORATION-8.63%84 821
VERTEX PHARMACEUTICALS..-27.97%22 456
ACTELION LTD21.56%18 675
More Results